• No results found

Echocardiographic evaluation of left ventricular function in ischemic heart disease Mollema, S.A.

N/A
N/A
Protected

Academic year: 2021

Share "Echocardiographic evaluation of left ventricular function in ischemic heart disease Mollema, S.A."

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Echocardiographic evaluation of left ventricular function in ischemic heart disease

Mollema, S.A.

Citation

Mollema, S. A. (2010, December 9). Echocardiographic evaluation of left ventricular function in ischemic heart disease. Retrieved from

https://hdl.handle.net/1887/16229

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/16229

Note: To cite this publication please use the final published version (if applicable).

(2)

Echocardiographic Evaluation of Left Ventricular Function in Ischemic Heart Disease

SjoErD A. MoLLEMA

Referenties

GERELATEERDE DOCUMENTEN

of the patients revealed improvement at 6-month follow-up and 7% at 12-month follow-up; (3) No significant differences in baseline characteristics were observed between early

Accordingly, the present study compares myocardial strain assessed using 2D speckle- tracking with the transmural extent of scar tissue on contrast-enhanced magnetic resonance

Logistic regression analysis (improvement in LVEF ≥5% as a binary value) showed that AFI global LV strain, peak level of troponin T, peak level of creatine phosphokinase, WMSI and

Univariable and multivariable Cox proportional hazards regression analyses were performed to relate clinical parameters (age, current smoking, diabetes, hyperlipidemia,

The main findings of the present study can be summarized as follows: 1) after 6 months of CRT 68% of patients were classified as clinical responders and 60% as

The main findings of the current study can be summarized as follows: 1) LV resynchronization following CRT occurs acutely and is sustained at 6-month follow-up, without

The results of the present study can be summarized as follows: 1) considerable improvement in LVEF with reduction in LV volumes is demonstrated at 3-month follow-up in heart failure

Peripheral blood cells were stained with HLA-A2.1 tetramers containing the tyrosinase368–376 peptide followed by staining with a panel of lineage antibodies, as described in